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CD1 molecules present lipid antigens to T cells. In this issue of Immunity, Scharf et al. (2010) solve the struc-
ture of CD1c, which has binding pockets suited for insertion of a variety of lipid antigens.A hallmark of the immune system is its
flexibility in recognizing different classes
of molecules, which appear in both path-
ogen and host cells. Over the past
decade, and to the surprise and initial
great skepticism of immunologists, it has
been discovered that, in addition to
peptides, lipids may also induce specific
T cell responses. Lipids (which include
glycolipids, microbial lipoglycans, and
many structurally different apolar organic
compounds) are proving to be an impor-
tant class of T cell-stimulatory antigens,
capable of firing pathogen-specific, anti-
tumor, autoimmune, and immunoregula-
tory responses.
Lipids stimulate specific T cells when
presented by CD1 molecules, which non-
covalently associate with b2-microglobu-
lin and resemble classical major histo-
compatibility complex (MHC) class I
molecules. In humans there are five CD1
genes (CD1A, B, C, D, and E) encoding
proteins involved in lipid-specific immu-
nity. In mice there is only one, Cd1d.
Human CD1a-d glycoproteins bind and
present lipid antigens to T cells, whereas
CD1e remains intracellular with chap-
erone functions in lipid presentation.
Comparison of the antigenic lipid struc-
tures has revealed two important
features. First, a large variety of lipid
structures can be antigenic. Second,
T cell-stimulatory lipids show amphi-
pathic properties in which the hydro-
phobic part is involved in CD1 anchoring,
whereas the hydrophilic part contributes
to TCR interaction.
The structure of antigenic lipids may
vary in different ways, including the
number, length, and unsaturation of alkyl
chains, the presence of alternative chiral
forms, and the anomeric form of glyco-
sidic bonds in the case of glycolipid anti-
gens. While each of these modifications
may influence lipid antigenicity, they alsorepresent a formidable task for CD1
proteins, which are not polymorphic and
have to accommodate so many different
structures. The large variety of antigen
structures represents an important dis-
tinction from MHC-bound peptides,
which instead have linear structures with
limited variations in size.
How CD1 proteins undertake this task
is a matter of intense investigation, in
which identification of CD1-lipid complex
structures is one of the main approaches.
In this issue of Immunity, Scharf et al.
(2010) describe the crystal structure of
CD1c, complexed with the mycobacterial
mannosyl-b1-phosphomycoketide (MPM)
antigen. This elegant work utilizes a series
of ‘‘tricks’’ to generate a stable hybrid
CD1c molecule, suitable for structural
studies, and provides new clues into how
lipid antigensarebound toCD1molecules.
As in other CD1 molecules, CD1c has
two hydrophobic antigen-binding pock-
ets, called A0 and F0. The CD1c A0 pocket
is characterized by a pole around which
the alkyl chain of the antigen coils and is
anchored. The A0 pocket continues into
the F0 one without a dividing wall.
Two important differences to other CD1
structures appear. The first one is the
presence of two open portals, called D0,
positioned at the end of the A0 pocket,
and E0, connecting the F0 pocket to the
exterior. The function of the portals is
not defined. They might be the outlets of
the terminal parts of very long chains
accommodating within the A0 or F0
pockets. This may represent a clever
adapting mechanism to bind different
lipids, although this mode of binding is
energetically unfavorable. Opening of
both portals is facilitated by a larger
distance between the a1 helix and b sheet
when compared to the other CD1 struc-
tures, thus providing increased flexibility
that might contribute to insertion and/orImmunity 33, Dextrusion of lipids and possibly facilitating
ready antigen exchange.
The second difference is an F0 pocket,
which is characterized by a deep groove
shape open to the solvent. As in other
CD1 molecules, the F0 pocket of CD1c
remains surroundedbyapolar aminoacids,
compatible with binding of acyl chains
or aromatic residues. A high intrinsic
disorder characterizes the a-helical
regions of the F0 groove, compatible with
binding of large peptide fragments.
The combination of these unique char-
acteristics provides CD1c with a promis-
cuous antigen-binding behavior. Indeed,
it may form antigenic complexes with
lipids containing one alkyl chain (MPM),
two alkyl chains (sulfatide) (Shamshiev
et al., 2002), or lipopetides formed by
one alkyl chain linked to a short peptide
(Van Rhijn et al., 2009). Furthermore,
among CD1 molecules CD1c has the
unique capacity of stimulating a popula-
tion of T cells expressing the gamma delta
chains of the T cell receptor (TCR gd)
(Spada et al., 2000). Although the nature
of the stimulatory antigen remains
unknown, it is probably a self-molecule
since the described CD1c-restricted
TCR gd cells are autoreactive.
An additional important finding of the
work of Scharf et al. (2010) is how the lipid
is anchored to CD1c. The A0 pocket has
a cavity larger than the one present in
other CD1 molecules. This allows binding
of lipids with bulky alkyl chains composed
of isoprenoid subunits, such as MPM.
This lipid is characterized by lateral methyl
groups that are present in othermycobac-
terial lipid antigens but not in mammalian
lipids. These methyls are stereospecific,
thus imposing a clockwise rotation of the
lipid chain around the pole of the A0
pocket. This type of accommodation
within the CD1c circular A0 pocket is
essential to fix and stabilize binding ofecember 22, 2010 ª2010 Elsevier Inc. 831








Figure 1. Schematic Representation of the Antigen-Binding Pockets of Human CD1
Molecules Involved in Antigen Presentation
Each CD1 molecule is suited to binding a variety of lipids although the nonpolymorphic nature. The struc-
ture of the A0 and F0 pockets of CD1c substantially differ from those of the other CD1 molecules. The A0
pocket has a large volume and an open terminal portal facilitating binding of methyl-branched very long
lipids. The F0 pocket is open to the solvent and may bind the peptidic part of lipopeptide antigens.
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Previewssingle alkyl chain antigens like MPM. As
alkyl chain appendices are unique to
bacteria, theymight represent themecha-
nistic tool facilitating responses to lipids
of microbial origin. It will be interesting to
compare the mode of binding of other
bacterial antigens containing lateral
methyl groups, whose number and posi-
tion are critical for antigenicity (Guiard
et al., 2009).
The authors also find that the hybrid
CD1c molecule binds a model lipopep-
tide, thus confirming a previous functional
study (Van Rhijn et al., 2009). As the
groove of the F0 pocket is only open on
the top it remains unknown whether or
not bound peptides must have an optimal
length, resembling peptides bound to
MHC class I molecules. However, it is
also possible that the amino acid chain
of some lipopeptide antigens might
contact the surface of the F0 pocket,
without being buried within the F0 groove.
In that case the peptide chain length
could be irrelevant for CD1c binding.
The unique structure of CD1c and its
promiscuous binding of structurally
different antigens outline two important
scenarios. The first regards the strategy
developed by the immune system to
present such a variety of lipid antigens. It
appears that despite a common general
structure, each CD1 has evolved unique
antigen-binding cavities suited to accom-
modating different lipid antigens. The
number of hydrophobic channels, their
interconnection, and complete or partially
closed cavities, together with the presence
of open portals, are all tailored features832 Immunity 33, December 22, 2010 ª2010instrumental to binding lipids with very
different structures (Figure 1). It is tempting
to speculate that selection by functional
benefits has fixed the structure of each
CD1 and perhaps is the cause of absent
functionalpolymorphism inCD1molecules.
The second scenario is how various
lipids become loaded onto CD1 mole-
cules despite their different structures,
each imposing unique biophysical con-
straints. It is probable that important
aspects concur such as the endosomal
compartment where CD1 molecules
recycle and the CD1 structure itself.
Recycling through late endosomal or
lysosomal compartments facilitates the
interaction with lipid transfer proteins
(LTPs) localized within the same compart-
ments and participating in lipid handling.
In addition, recycling in these deep endo-
somal stations exposes CD1b, c, and
d (the molecules reaching these compart-
ments) to an environment with low pH.
A direct consequence of this may be
a transient and partial CD1 denaturation
that facilitates lipid exchange, as shown
with CD1b (Relloso et al., 2008).
This strategy does not apply to CD1a
and some CD1c molecules recycling
through early endosomal compartments,
which lack resident LTP and acidic pH.
Interestingly, both CD1a and CD1c have
an incomplete F0 pocket, which probably
facilitates antigen loading even in the
absence of pH-induced structural
changes (Geho et al., 2000; Manolova
et al., 2006). Curiously, CD1a, but not
other CD1 molecules, also shows weak
binding to b2-microglobulin that facili-Elsevier Inc.tates exchanges of different b2-microglo-
bulin partner molecules (Kefford et al.,
1984). During b2-microglobulin ex-
change, transient structural changes
might occur, thus contributing to lipid
antigen binding. Are the F0 open pocket
and weak association with b2-microglo-
bulin additional examples of selection-
induced structural characteristics of
certain CD1 molecules?
The study of Scharf et al. (2010)
completes the analysis of CD1 molecules
directly interacting with the TCR. Only the
structure of CD1e remains unknown, and
it will be interesting to see whether its
chaperone function is associated with
important structural differences from
CD1 molecules directly involved in
antigen presentation.
Overall comparison betweenCD1mole-
cules reveals the easy virtue of CD1c,
a molecule that binds a large variety of
ligands, recycles in both early and late en-
dosomes, is more widely expressed than
CD1a and CD1b, and stimulates both
TCR ab and gd cells. Moreover, CD1c is
the restriction molecule of a large number
of circulating T cells, indicating an impor-
tant function in shaping the repertoire of
T cell response (de Lalla et al., 2010).
The study of lipid recognition is
disclosing unique immunological mecha-
nisms and structures of main physiolog-
ical relevance. All these discoveries were
totally unforeseen a few years ago.
Further investigations in this field will
surely bring us additional surprises, unex-
pected even to most imaginative and
prophetic immunologists.REFERENCES
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Interferon regulatory factor 3 (IRF3) and IRF7 modulate the transcription of type I interferon. In this issue
of Immunity, Yu and Hayward (2010) identify RAUL, the bona fide ubiquitin ligase that regulates turnover
of IRF3 and IRF7.Host protection against viral infection is
orchestrated through specific pathogen
sensing, complex signaling pathways,
and a diversity of protective responses.
The initial efforts of the infected host cell
are to limit virus replication by engaging
a broad spectrum of innate antiviral mech-
anisms while signaling the initiation of
adaptive immunity. Microbial pathogens
express defined pattern-associated mo-
lecular patterns (PAMPs) that are detected
by pattern-recognition receptors (PRRs).
Thus far, three PRR families have been
identified: the Toll-like receptors (TLRs),
the cytoplasmic retinoic acid inducible
gene (RIG-I)-like receptors (RLRs), and
thenucleotide-bindingandoligomerization
domain (NOD)-like receptors (NLRs) (Akira
et al., 2006; Takeuchi and Akira, 2010).
Engagement of a PRR will activate a
specific signaling cascade culminating in
the expression of downstream target
genes such as type I interferon (IFN),
inflammatory mediators, and host restric-
tion factors. Common to most PRR sig-
naling events is the activation of interferon
regulatory factors—IRF3 or IRF7, critical
transcriptional activators of type I IFN
gene activation. IRF3 and/or IRF7 are
phosphorylated by the noncanonical
IkB -related kinases (IKK) TANK-binding
kinase (TBK1) and IKK3 at key serine resi-dues in the C terminus of the protein after
TLR3, TLR4, or RIG-I stimulation.
The active state of these transcription
factors is tightly regulated by posttransla-
tional modifications such as phosphoryla-
tion, ubiquitination, and the addition of
interferon stimulated gene 15 (ISG15),
also known as ISGylation. Recognition
that protein ubiquitination functions as a
major regulator of signal transduction
has refocused the search for negative
regulators to the identification of E3
ligases with the potential to modulate
IRF activity and the IFN response. As
with the identification of novel kinases,
significant effort has been directed to the
discovery of E3 ligases because they
define the specificity and complexity that
is characteristic of the ubiquitination pro-
cess. In this issue, Yu and Hayward
(2010) identify RAUL as the bona fide E3
ligase that conjugates K48-dependent
Ub chains to IRF3 and IRF7, leading to
proteasome mediated degradation.
Ubiquitination, like phosphorylation, is
a reversible process controlled by a limited
numberofdeubiquitinases that specifically
cleave ubiquitin chains (Ribet andCossart,
2010). Ubiquitin (Ub) is a small peptide of
76 amino acids that is highly conserved in
all eukaryotic cells. Ub becomes conju-
gated to a target protein via formation ofan isopeptide bondbetween itsC terminus
(G76) and the 3-amino group of an
acceptor Ub lysine residue (most
commonly studied are K48 or K63)—or
directly to the amino terminus of the target
protein. Alternatively, head-to-tail linked
Ubmoieties havebeendescribed recently,
as part of the novel process of linear ubiq-
uitination (Clague and Urbe, 2010). This
highly organized posttranslational modifi-
cation requires the sequential action of
threeenzymes:E1-E2-E3.A ubiquitin-acti-
vating enzyme (E1) forms a thiol ester with
the carboxyl group of Ub, thereby acti-
vating it for nucleophilic attack. A conju-
gating enzyme (E2) transiently carries the
activated Ub molecule as a thiol ester,
and the E3 ligase transfers the activated
Ub from the E2 to the substrate.
A common strategy of many viruses is
to target key antiviral signaling proteins
for proteasomal degradation by using
either viral or host ubiquitin ligases
(Viswanathan et al., 2010). Pathogens
hijack certain posttranslational modifica-
tions to preferentially target specific host
pathways to promote their replication
and propagation and to escape from the
immune system (Ribet and Cossart,
2010) . Viral proteins that usurp the ubiqui-
tin-proteasome pathway include the
E6- associated protein (E6-AP) of humanecember 22, 2010 ª2010 Elsevier Inc. 833
